In the present study, the mode of action and therapeutic potential of flavopereirine in the suppression CRC cell growth via the P53-P21 and JAKs-STATs-cMyc signal pathways were evaluated in vitro and in vivo. Here, TP53 is linked to colorectal carcinoma.